InvestorsHub Logo
Followers 8
Posts 290
Boards Moderated 0
Alias Born 04/06/2019

Re: None

Thursday, 05/09/2024 7:53:28 AM

Thursday, May 09, 2024 7:53:28 AM

Post# of 427500
On a more positive note, HLS highlights in Canada included:
Vascepa unit demand increased by 54% compared to Q1 2023.
The number of consistent prescribers2 for Vascepa increased 112% compared to Q1 2023.
Vascepa net revenue was C$4.5 million, up 27% compared to C$3.5 million in Q1 2023.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News